Loading…
Pharvaris N.V. is projected to rise to $48.72 by 2027, a +39% move from its current price of $35.07. PHVS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $34.35 | $35.09 | $35.85 | +0.06% |
| Jul 15 | $34.07 | $35.12 | $36.19 | +0.13% |
| Jul 16 | $33.86 | $35.14 | $36.46 | +0.19% |
| Jul 17 | $33.69 | $35.16 | $36.69 | +0.26% |
| Jul 18 | $33.55 | $35.18 | $36.90 | +0.32% |
| Jul 19 | $33.42 | $35.21 | $37.09 | +0.39% |
| Jul 20 | $33.30 | $35.23 | $37.27 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $33.30 | $35.23 | $37.27 | +0.46% |
| Week 2 | $32.68 | $35.39 | $38.33 | +0.91% |
| Week 3 | $32.24 | $35.55 | $39.20 | +1.37% |
| Week 4 | $31.90 | $35.71 | $39.98 | +1.83% |
| Week 5 | $31.62 | $35.88 | $40.70 | +2.30% |
| Week 6 | $31.39 | $36.04 | $41.38 | +2.76% |
| Week 7 | $31.18 | $36.20 | $42.03 | +3.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pharvaris N.V. is a late-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases with unmet needs, covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant.
Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
PHVS is the stock ticker for Pharvaris N.V. and is currently priced at $34.71 per share. The company has a market cap of $2.43B and is ranked 1818 by market capitalization. The current price sits within a 30-day range of $29.99 to $40.17, and the stock presents a bullish technical backdrop.
A major floor 27.7% below — a decisive break under it would weaken the trend.
The nearest floor, 17.4% below — buyers have tended to step in here.
Price is pressing into resistance (2.5% away) — a breakout level to watch.
A major ceiling 15.0% above — clearing it would confirm fresh momentum.
Key PHVS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PHVS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $34.95 | Buy | $35.08 | Sell |
| MA 10 | $34.59 | Buy | $34.57 | Buy |
| MA 20 | $33.54 | Buy | $33.67 | Buy |
| MA 50 | $31.57 | Buy | $31.88 | Buy |
| MA 100 | $29.52 | Buy | $30.07 | Buy |
| MA 200 | $27.18 | Buy | $27.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.65 | Neutral |
| Stoch RSI (14) | 45.43 | Neutral |
| CCI (20) | 94.48 | Neutral |
| Williams %R (14) | -30.07 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 5.66 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 69.93 | Neutral |
| TRIX (15) | 0.48 | Buy |
| Awesome (5,34) | 2.72 | Buy |
| Ultimate (7,14,28) | 59.41 | Neutral |
| Momentum (10) | 1.77 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 35.88 | Sell |
| ADX (14) | 22.06 | Buy |
| ATR (14) | 0.63 | Info |
The 30-day technical picture is bullish with RSI14 at 70. The chart shows a moving-average anchor with SMA50 at $30.62 and SMA200 at $26.76. Near-term support is at $28.81 and resistance at $34.71, framing a 30-day price range from $29.99 to $40.17.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $24.05 | $35.07 | $46.89 | 0% | Neutral | |
| $39.58 | $48.72 | $62.93 | +39% | Bullish | |
| $48.24 | $60.66 | $80.74 | +73% | Bullish | |
| $57.55 | $73.65 | $100.35 | +110% | Bullish | |
| $60.77 | $78.98 | $109.76 | +125% | Bullish | |
| $65.91 | $86.86 | $122.84 | +148% | Bullish | |
| $77.09 | $102.91 | $147.83 | +193% | Bullish | |
| $80.92 | $109.35 | $159.33 | +212% | Bullish | |
| $96.65 | $132.10 | $195.02 | +277% | Bullish | |
| $117.20 | $161.95 | $242.02 | +362% | Bullish | |
| $164.01 | $238.00 | $374.46 | +579% | Bullish | |
| $342.42 | $539.39 | $915.65 | +14.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $24.05 | $35.07 | $42.24 | +0.00% |
| August 2026 | $31.60 | $37.07 | $44.49 | +5.72% |
| September 2026 | $31.54 | $37.21 | $45.05 | +0.36% |
| October 2026 | $30.87 | $36.58 | $44.62 | -1.68% |
| November 2026 | $31.23 | $37.15 | $45.60 | +1.56% |
| December 2026 | $31.81 | $37.98 | $46.89 | +2.24% |
Click any year to see its month-by-month PHVS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PHVS is projected to trade between $24.05 and $46.89, averaging $35.07 — a potential gain of 0% from today's $35.07. Price action looks broadly range-bound.
Pharvaris N.V.'s 2027 outlook centres on $48.72, within a $39.58 to $62.93 range. That is up +39% on the projected 2026 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, PHVS could reach as high as $80.74, with a base case around $60.66 and support toward $48.24 — roughly +73% from $35.07. Momentum favours further upside here.
Expect PHVS to range from $57.55 to $100.35 through 2029. The $73.65 average target implies a +110% move from current prices. That is up +21% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PHVS price prediction for 2030 points to an average of $78.98 (low $60.77, high $109.76) — a potential gain of +125% on today's $35.07. Momentum favours further upside here.
In 2031, PHVS is projected to trade between $65.91 and $122.84, averaging $86.86 — a potential gain of +148% from today's $35.07. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Pharvaris N.V.'s 2032 outlook centres on $102.91, within a $77.09 to $147.83 range. That is up +18% on the projected 2031 average. That marks a +193% change versus current levels. Momentum favours further upside here.
By 2033, PHVS could reach as high as $159.33, with a base case around $109.35 and support toward $80.92 — roughly +212% from $35.07. Buyers look set to stay in control over this stretch.
Expect PHVS to range from $96.65 to $195.02 through 2034. The $132.10 average target implies a +277% move from current prices. That is up +21% on the projected 2033 average. Momentum favours further upside here.
The PHVS price prediction for 2035 points to an average of $161.95 (low $117.20, high $242.02) — a potential gain of +362% on today's $35.07. Buyers look set to stay in control over this stretch.
In 2040, PHVS is projected to trade between $164.01 and $374.46, averaging $238.00 — a potential gain of +579% from today's $35.07. That is up +47% on the projected 2035 average. Momentum favours further upside here.
Pharvaris N.V.'s 2050 outlook centres on $539.39, within a $342.42 to $915.65 range. That is up +127% on the projected 2040 average. That marks a +14.4x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PHVS today (≈ 28.5144 PHVS) could be worth
$15,380.47
+$14,380.47 (+1438%) by 2050 · US Dollar
Based on the average projected PHVS price of $539.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PHVSwould be worth at today's price.
$1,000 invested in PHVS on Jul 10, 2025 (≈ 50.428644 PHVS) would be worth
$1,768.53
+$768.53 (+76.9%) today · 1.77× · US Dollar
Based on a PHVS entry price of $19.83 vs. today's $35.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $33.86 | $1,035.74 | +3.6% |
| 1 month ago | $31.51 | $1,112.98 | +11.3% |
| 3 months ago | $26.63 | $1,316.94 | +31.7% |
| 6 months ago | $26.1 | $1,343.68 | +34.4% |
| 1 year ago | $19.83 | $1,768.53 | +76.9% |
| All time (5.0y) ago | $15.21 | $2,305.72 | +130.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PHVS forecast.
Our base-case forecast reaches $70.00 around 2029.
Implied market cap at $70.00: $4.89B
The multi-year forecast paints a rising path from 2026 onward. In 2026, the average price is $34.71 with a forecasted range from $24.05 to $46.53 and a neutral sentiment. By 2027, the average price is $48.54 with ROI 39.9 and bullish sentiment, followed by 2028 with average $60.93 and ROI 75.5; 2029 with average $72.23 and ROI 108.1; 2030 with average $77.82 and ROI 124.2.
The trajectory continues through 2031 ($86.81 average, ROI 150.1), 2032 ($100.91 average, ROI 190.7), 2033 ($107.20 average, ROI 208.8), 2034 ($131.40 average, ROI 278.6), and 2035 ($159.47 average, ROI 359.4). Into the next decade, 2040 shows an average of $236.24 with ROI 580.6 and bullish sentiment, and 2050 projects an average of $522.01 with ROI 1403.9 and bullish sentiment. These are estimates and not guarantees, but the outlook indicates substantial upside over a long horizon along with inherent uncertainties.
Tap a question to reveal the answer.
The 2030 forecast lists an average price of $77.82, with a minimum of $59.54 and a maximum of $108.93; the forecast shows a ROI of 124.2 and a bullish sentiment.
Yes—the 2029 forecast shows a maximum of $99.07 and an average of $72.23, with a bullish sentiment and ROI of 108.1.
PHVS is currently priced at $34.71 per share and has a market cap of $2.43B.
The 2040 forecast shows an average price of $236.24 with ROI 580.6 and a bullish sentiment, while the 2050 forecast shows an average price of $522.01 with ROI 1403.9 and bullish sentiment.
Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Pharvaris N.V. Community Discussion
0Share your Pharvaris N.V. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.